ArticleJournal of pharmaceutical health care and sciences2019
Evaluation of adverse events focusing on infection associated with infliximab originator and biosimilar using a spontaneous reporting system database.
Iku Niinomi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.